EXACT Sciences Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (39)

Latest Posts

About This Stock More About This Stock
ARKK Stocks Breakdowns And Bounces
Article By: Bespoke Investment Group
Friday, May 7, 2021 2:48 PM EDT
After struggling for most of the past couple of months, momentum and Tech stocks are broadly outperforming today.
In this article: ICE, REGN, PCAR, TRMB, COIN, EXAS, ARKK, NVTA, TDOC, CRSP, IOVA
Read
E High Tide
Article By: Vivian Lewis
Monday, March 29, 2021 7:11 PM EDT
The huge container ship blocking the Suez Canal was freed today. This somewhat reduced the up move of Chinese exporter shares
In this article: AZN, CAE, LAZ, LGI, SMFG, SAN, AAIGF, ANCUF, ANFGF, ESALY, JMPLY, MSBHF, NILSY, SLFPY, TMRAY, CBOE, EXAS, UUUU, ZYME, CSAN
Read
7 ARKK Stocks With Technical Support And Upside Potential
Article By: Benzinga
Saturday, March 13, 2021 3:29 PM EDT
Shares of the ETF ARKK have been down 18.9% in the past month, but Bank of America technical analyst Stephen Suttmeier said Friday that the technical picture for ARKK and several of its top holdings is more bullish than it may seem at first glance.
In this article: ARKK Also: TER, EXAS, PYPL, PSTG, FATE, CRSP, TSLA
Read
EC The Brave New Genomic World
Article By: Nelson Alves
Thursday, February 25, 2021 8:19 PM EDT
It is not just genomics changing the pharmaceutical sector. AI is also providing a helping hand to accelerate the genomics revolution.
In this article: L, ILMN, GOOG, PACB, EXAS, MRNA, GOOGL, NVTA, CRSP, BNTX, TXG, BNGO, ARKG
Read
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Article By: Benzinga
Sunday, February 14, 2021 5:56 PM EDT
Biotech stocks advanced in the week ended Feb. 12, thanks to market strength and company-specific catalysts. Small and mid-cap earnings, multiple conference presentations, data readouts, and a slew of IPOs were all part of the week's news flow.
In this article: EBS, SNY, REGN, EXAS, MEDP, OCGN, WST, IART, GMED, SWAV
Read

Latest Tweets for $EXAS

No tweets yet!

$EXAS

Exact Sciences: Poised For Further Growth
James Dean Samuels 11/22/2018 6:59:36 PM

Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS

Exact Sciences: Poised For Further Growth
Beating Buffett 11/9/2018 4:28:18 AM

Article is a good summary and is likely representative of the future for $EXAS.

1 to 2 of 2 comments